Bazedoxifene, a GP130 Inhibitor, Modulates EMT Signaling and Exhibits Antitumor Effects in HPV-Positive Cervical Cancer
Persistent HPV (Human Papillomavirus) infection is the primary cause of cervical cancer. Despite the development of the HPV vaccine to prevent infections, cervical cancer is still a fatal malignant tumor and metastatic disease, and it is often difficult to treat, so a new treatment strategy is neede...
Main Authors: | Leekyung Kim, Sun-Ae Park, Hyemin Park, Heejung Kim, Tae-Hwe Heo |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-08-01
|
Series: | International Journal of Molecular Sciences |
Subjects: | |
Online Access: | https://www.mdpi.com/1422-0067/22/16/8693 |
Similar Items
-
Bazedoxifene as a novel GP130 inhibitor for Colon Cancer therapy
by: Jia Wei, et al.
Published: (2019-02-01) -
Effects of conjugated estrogen and bazedoxifene on hemostasis and thrombosis in mice
by: Emmanuelle Noirrit, et al.
Published: (2019-06-01) -
Effectiveness of bazedoxifene in preventing glucocorticoid-induced bone loss in rheumatoid arthritis patients
by: Soo-Kyung Cho, et al.
Published: (2021-07-01) -
Bazedoxifene Suppresses Intracellular Mycobacterium tuberculosis Growth by Enhancing Autophagy
by: Qi Ouyang, et al.
Published: (2020-04-01) -
Bazedoxifene Attenuates Abdominal Aortic Aneurysm Formation via Downregulation of Interleukin-6/Glycoprotein 130/Signal Transducer and Activator of Transcription 3 Signaling Pathway in Apolipoprotein E–Knockout Mice
by: Dan Yan, et al.
Published: (2020-04-01)